Single-ascending Dose Study of Kylo-11 in Healthy Subjects

NCT06363851 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Diseases

Interventions

DRUG: Kylo-11
DRUG: Placebo

Sponsor

Kylonova (Xiamen) Biopharma co., LTD.